Clinical Trial Update: Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating pyrotinib combined with brain radiotherapy for patients with breast cancer and brain metastases (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Pyrotinib (pyrotinib)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer, Brain Metastases | Phase 1, Phase 2 | Status: UNKNOWN